Neith Corporation (6236.TWO)
TWD 28.95
(0.0%)
TWD 28.95
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -48.85 Million TWD | -67.21% |
| 2022 | -23.84 Million TWD | -312.65% |
| 2021 | -5.77 Million TWD | 35.8% |
| 2020 | -9 Million TWD | 69.16% |
| 2019 | -29.18 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -11.17 Million TWD | 2.49% |
| 2024 Q2 | -3.39 Million TWD | 22.76% |
| 2023 FY | -39.86 Million TWD | -67.21% |
| 2023 Q4 | -11.46 Million TWD | -20.93% |
| 2023 Q3 | -9.47 Million TWD | -60.74% |
| 2023 Q2 | -5.89 Million TWD | 54.76% |
| 2023 Q1 | -13.03 Million TWD | -2.9% |
| 2022 Q4 | -12.66 Million TWD | 0.0% |
| 2022 FY | -23.84 Million TWD | -312.65% |
| 2021 FY | -5.77 Million TWD | 35.8% |
| 2020 FY | -9 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 117.333% |
| Level Biotechnology Inc. | 67.55 Million TWD | 172.321% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 24.111% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 42.487% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 78.693% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 42.521% |
| Visgeneer Inc. | -21.15 Million TWD | -130.89% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 105.46% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 160.55% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -639.092% |
| Enimmune corporation | -243.47 Million TWD | 79.935% |
| TaiRx, Inc. | -214.69 Million TWD | 77.245% |
| EirGenix Inc. | -1.03 Billion TWD | 95.266% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 177.136% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 32.238% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 47.658% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 72.327% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 302.194% |
| Lukas Biomedical Inc. | -43.56 Million TWD | -12.153% |
| RBC Bioscience Corporation | 14.53 Million TWD | 436.02% |
| BiOptic Inc. | 44.05 Million TWD | 210.898% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 13.912% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 22.062% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 25.776% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 114.623% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 91.886% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 95.975% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 30.784% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 70.611% |
| GlycoNex Incorporation | -259.86 Million TWD | 81.2% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -2068.398% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -7.367% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 95.546% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 92.962% |
| VBI | -16.13 Million TWD | -202.839% |
| CHO Pharma, Inc. | -268.99 Million TWD | 81.839% |
| NaviFUS Corp. | -76.42 Million TWD | 36.077% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 48.003% |
| Sinew Pharma Inc. | -186.25 Million TWD | 73.77% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 27.834% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 130.569% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 86.994% |
| AP Biosciences Inc | -347.47 Million TWD | 85.94% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 96.038% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 22.273% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -1629.958% |
| Intech Biopharm Corporation | -304.39 Million TWD | 83.951% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 95.545% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -17.772% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 71.187% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 114.465% |
| TCI GENE Inc. | 10.04 Million TWD | 586.158% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 61.61% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 84.297% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 76.978% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 1522.656% |
| PharmaEngine, Inc. | 277.18 Million TWD | 117.625% |
| Savior Lifetec Corporation | -2.42 Million TWD | -1918.76% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 72.035% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 97.662% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 60.331% |
| Acepodia, Inc. | -435.97 Million TWD | 88.794% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 89.988% |